Valens GroWorks Laser Focused on Quality Control Throughout Supply Chain
June 26th, 2018
Exclusive, News, Top Story
As the cannabis industry comes of age, gains acceptance among a wider population, and develops more rigorous standards, companies that produce trusted, consistent, safe, and proven products should tend to win out. The science of cannabis is really in its infancy due to long-standing legal difficulties with studying the plant, but it is moving forward now at increasing speed. Along with the science of how cannabis works comes the necessity to consistently produce and test for certain characteristics, like cannabinoid and terpene profiles, in order to achieve the desired results. And, as several Canadian producers have discovered, selling products with unapproved additives can lead to a disastrous erosion of public trust.
Valens GroWorks (CSE: VGW) is a licensed dealer and a licensed producer applicant going to great lengths to ensure quality and consistency throughout its operations. With three subsidiaries that cover the product life cycle from seed to sale, and a company-wide commitment to adhering to the strictest standards of quality, Valens is aimed squarely at the high value market for cannabis extracts and related products both in Canada and internationally.
ISO Certified Lab
Valens recently announced that its wholly-owned lab, Supra THC Services, obtained ISO 17025 accreditation for cannabis testing. Achieving such accreditation validates the laboratory and its results, engendering trust for the company’s clients. According to the International Organization for Standardization (ISO), this certification standard makes it so “test reports and certificates can be accepted from one country to another without the need for further testing, which, in turn, improves international trade.”
Supra THC Services lab equipment
Supra is the first cannabis-focused, licensed Canadian lab to achieve the certification. With recent product recalls due to pesticides fresh in both consumers’ and licensed producers’ minds, the ISO accreditation could be a major boon to the company’s testing business. But the implications go deeper than that. Valens is developing its own line of products, utilizing the company’s state of the art production and extraction techniques. Having these products tested in the ISO-certified lab should help the company validate its products and meet even the strictest regulations, whether in Canadian or international markets.
Supply Chain Control
One thing about extracted and derivative products is sure: like the old computer programming adage GIGO, if you put garbage in to the front end of the process, you’ll get garbage out of the back end. In order to produce consistent and high quality end products, the best cannabis raw material must be used. Right now, the highest standards for production in the industry come out of Europe. With that market emerging as a major target for cannabis trade, companies are smart to meet those standards.
Valens Farms, another Valens GroWorks subsidiary, recently announced the progress being made on the company’s 400,000 square foot greenhouse cultivation and production facility in Armstrong, BC. The facility is a joint venture with a real estate development company, and is already permitted to expand up to 800,000 sf if the companies choose. Importantly, it is being built to European Union Good Manufacturing Practices (GMP). The addition of this high volume, state of the art facility will allow the company to ensure the highest quality of cannabis as a starting point for its derived products.
Those products will be developed through the company’s third subsidiary, Valens AgriTech. That company’s 17,000 sf facility houses cultivation, extraction, and research activities and is in the process of becoming GMP-certified. Valens also recently moved its Supra THC Services operation there, increasing the company’s efficiency and utilizing the synergies between the subsidiaries. Valens AgriTech holds a Dealer’s License that allows for cultivation, processing, oil production, and sales of those oils through licensed producers. The company is in the late stages of the ACMPR application process to become its own Licensed Producer.
Put it all together and you have a company that is committed to the highest quality standards on the planet throughout the cannabis life cycle. Valens may seem like a small licensed producer located in the heart of British Columbia, and it is. But the company’s goals extend far beyond the Okanagan region, and it appears that the foundation is in place to achieve those goals.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://www.cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.